Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-038493
Filing Date
2017-07-26
Accepted
2017-07-26 21:03:33
Documents
2
Period of Report
2017-07-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v471462_3.html 3  
1 OWNERSHIP DOCUMENT v471462_3.xml 3 1607
2 EXHIBIT 24 v471462_ex24.htm EX-24 4797
  Complete submission text file 0001144204-17-038493.txt   7743
Mailing Address PO BOX 326 PARK CITY UT 84060
Business Address
Climaco John M (Reporting) CIK: 0001546797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37758 | Film No.: 17984196

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations